Skip to main content
Erschienen in: Diabetology & Metabolic Syndrome 1/2021

Open Access 01.12.2021 | Research

Microvascular complications and its predictors among type 2 diabetes mellitus patients at Dessie town hospitals, Ethiopia

verfasst von: Mohammed Abdu Seid, Yonas Akalu, Yibeltal Yismaw Gela, Yitayeh Belsti, Mengistie Diress, Sofonias Addis Fekadu, Baye Dagnew, Mihret Getnet

Erschienen in: Diabetology & Metabolic Syndrome | Ausgabe 1/2021

Abstract

Background

Diabetes mellitus is a serious metabolic disorder which becomes common in middle and low incomes countries since few decades. Microvascular complications include retinopathy, neuropathy and nephropathy all of which can lead to disability, dependency, accelerate their morbidity, and mortality. In Ethiopia, there is paucity data regarding this topic. Hence, this study aimed to assess prevalence of microvascular complications and its predictors among type 2 diabetes mellitus patients.

Methods

Cross-sectional study was conducted from February to March 2020 at Dessie town hospitals. We used simple random sampling to recruit study participants and pre-tested interviewer administered questionnaire to collect the data. Data was entered into Epi-Data 3.1 and exported to SPSS-23 for analysis. Binary logistic regression was done to select potential variables to be adjusted at p ≤ 0.25. After running multivariable regression, variables with a p-value ≤ 0.05 were declared as statistically significant.

Results

Three hundred and thirty-five type 2 DM patients participated in the study, of which 54.6% were males. One hundred and twenty-seven [37.9% (95% CI 32.5%–43.3%)] of diabetes mellitus had at least one microvascular complications. These were retinopathy 24.8%, nephropathy 16.1%, and neuropathy 8.1%. Age 60–87 years (AOR = 2.76, 95% CI 1.02–7.46), duration of diabetes > 5 years (AOR = 4.09, 95% CI 2.40–6.96), mellitus and co-morbid hypertension (AOR = 3.52, 95% CI 2.09–5.95), were statistically significant.

Conclusions

In this study, diabetic microvascular complications are prevalent. Increasing the age of participants, longer duration of diabetes mellitus and co-morbid hypertension were independent predictors. Health workers should give emphasis for diabetes mellitus through early screening and health education, abrupt medication for aged patients with long duration of diabetes mellitus, and hypertension, and also early detection and management of microvascular complication.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AOR
Adjusted odd ratio
BMI
Body mass index
CI
Confidence level
COR
Crude odd ratio
DM
Diabetes mellitus
FBS
Fasting blood sugar
SPSS
Statistical Package for Social Sciences

Background

Microvascular complications are sequels of diabetes mellitus following uncontrolled chronic hyperglycemia which includes diabetic nephropathy, neuropathy and retinopathy, that are caused by pathological changes in capillaries [1, 2]. The time to develop microvascular complications is much faster and common than macrovascular complication [3].
Diabetes mellitus (DM), commonest metabolic illness, is one of the major public health concern worldwide [4]. Diabetes burden has been rising more rapidly in low and middle income countries than in high income countries [3, 5], which is attributed to the effect of globalization, life style modification (change in diet type and pattern) and physical inactivity (being obese) [6].
Nowadays, the number of peoples living with diabetes increases rapidly and the disease become pandemic. Since few decades, the prevalence of type 2 diabetes has increase radically in all countries of the globe. It is about 422 million people have diabetes mellitus worldwide, and low-and middle-income countries are majorly the victims [5]. The disorder is also predicted to 578 million in 2030 and inflated to 700 million by the year 2045 [7]. In other words, nearly 1 in every 11 adults has diabetes globally, of which more than 3/4th is type 2 DM [3]. Morbidity and mortality in chronic diabetes mellitus is now common that is more than four million people aged 20–79 years were estimated to die from diabetes related complications [7]. Adequate data on tendencies of microvascular diabetes complications and other evolving complications are lacking and so that conclusions are incomplete [8].
Following the increase number of type 2 DM, its microvascular complication is rising proportionally and substantially [9]. Diabetic microvasculature is highly susceptible for damage due to chronic hyperglycemia and genetic predisposition, leading to complications of essential organs such as the kidneys, the eyes and the nervous system. Diabetic nephropathy is the foremost cause of serious renal disease, diabetic retinopathy (DR) is the amongst cause of blindness in diabetes population and that of diabetic neuropathy is the main attributing factor for diabetic foot ulcer and amputation [9, 10].
Almost all organs are affected and people suffer from serious morbidity and mortality due to type 2 DM related complications. The commonest type 2 DM microvascular complications are retinopathy, neuropathy and nephropathy that are present at the time of patient diagnosis [4, 11]. Chronic diabetes prone to lose more than half of the direct health costs following complications [12]. Indeed, they are eligible to develop disability, accelerate mortality and fail to avail work on regular basis due to the illness [1, 8, 13].
Globally, around 1/5th (18.8%) of type 2 diabetes mellitus developed microvascular complications [14], and this proportion was increased to 45% in middle east [15] and 47.8% in African diabetes [16]. In particular, different studies were conducted in different countries and revealed varying prevalence which is supported in USA 77% [17], Brazil 41.6% [18], China 57.5% [19], Spain 25.2% [20], Bangladesh 50.4% [21], Greenland 68% [12], Kuwait 61.6% [22], Saudi Arabia 35.4% [23], and Ghana 35.3% [24].
The emerging prevalence of diabetes and its complication also noted in Ethiopia. For instance, microvascular complication of type 2 diabetes is prevalent in Gondar, Ethiopia 20.4% [25], wollega hospitals 31.2% [26], Gurage zone 61% [27], Jimma university hospital 41.5% [28], Mettu Karl Referral Hospital 38.5% [29], and Debre tabor Hospital 43.9% [30].
Different literature showed that a number of factors are associated with microvascular diabetic complications. These factors could be grouped as socio-demographic factors (age, sex, and marital status), behavioral factors (obesity, diet) and clinical factors (glycemic control, and duration of diabetes, comorbidities (hypertension) and medication). In particular studies, being female [28, 31], age [14, 16, 19, 22, 26, 30, 32, 33], marital status (single or divorced) [19, 27], family history of diabetes mellitus [15, 26, 28, 31], longer duration of diabetic [9, 16, 19, 22, 23, 26, 27, 3032, 34], hypertension [9, 16, 1820, 22, 23, 26, 27, 30, 32, 34, 35], obesity [22, 27, 31], poor glycemic control [18, 22, 25, 27, 28, 33, 34], adherence to diet [16, 22, 35], mixed medication [26, 30] and insulin therapy only [22] were predictors for microvascular complications among type 2 diabetes mellitus patients.
In Ethiopia, people living with type 2 DM ranged 2% to 7% and its long term sequels are the major causes of morbidity and mortality besides to its economic crisis and social stigma [36]. Literature sources that showed factors exacerbating diabetic complications were too limited. Hence, this study was aimed to assess prevalence of microvascular complications and its predictors among type 2 diabetes mellitus patients in Dessie town hospitals.

Methods and materials

Study design, setting and period

Cross-sectional study was conducted from February to March 2020 at Dessie town hospitals. Dessie Town is found 400 km Northeast of Addis Ababa, the capital town of Ethiopia. Around fourteen thousand diabetes patients were served in a total of 5 hospitals. Diabetes patients have follow-up dates from Monday to Friday.

Study population and eligibility

Type 2 diabetes clients visiting the Hospitals at a regular base (every 3 months) as outpatient and available during the period of data collection were participants and eligible for this study. Those individuals living with diabetes who were critically ill or unconscious, gravid women at 2nd trimester and above were excluded.

Determination of sample size and sampling

Sample size was estimated considering the following assumptions: p = 0.705 [33], 95% CI, and 5% margin of error. Hence, the calculated sample size was 319 and by adding 5% oversampling to account for non-respondents, we got a total of 335. We used simple random sampling technique to recruit study participants and allocated proportionally for each hospital of Dessie town.

Study variables

  • Dependent variable: Microvascular complications
  • Independent variable: Socio-demographic factors (age, sex, residence, marital status, occupation), behavioral factors (physical activity, obesity, diet) and clinical factors (glycemic control, and duration of diabetes mellitus, comorbidities (hypertension) and anti-diabetic medication)

Operational definitions

Microvascular complications: Diabetes mellitus patients with one or more of the following complications: diabetic nephropathy, diabetic retinopathy, and peripheral neuropathy [14] of known diabetes or newly diagnosed diabetes.
Physical activity: Diabetes mellitus individuals who perform at least 150 min per week (3 days) of moderate intensity exercise regarded as Good otherwise poor physical activity [37].
Glycemic control level: It was good glycemic control when fast blood sugar (FBS) was below 130 mg/dL and above indicated value was regarded as poor [38].
Obesity: A client with body mass index (BMI) of ≥ 30 kg/m2. It has three categories, category 1 (BMI: 30–34.9 kg/m2), category 2 (BMI:35–39.9 kg/m2) and category 3 or extreme obesity ( BMI: ≥ 40 kg/m2) [39].
Adherence to diet: Diabetes mellitus individuals adjust life style (diet) as recommended for more than 3 days in last seven consecutive days.

Data collection instrument, procedure and quality control

Data were collected using a semi-structured interviewer administered questionnaire consisting socio-demographic factors, behavioral & clinical predictors of microvascular complication in type 2 diabetes. These complications were diagnosed based on the physical, clinical, laboratorial and other requested findings and decision by the physician. Fundus ophthalmoscopy examination (the presence of neovascularization, hemorrhage spot, vitreous hemorrhage, microaneurysm, macular lesion and cotton wool spot) was done to diagnose diabetic retinopathy. For neuropathy, clinical assessment like history of numbness, paresthesia, tingling sensation and tests for vibration sensation was used. Likewise, symptoms such as swelling of feet, hands or eyes, urinary frequency and urgency, BP measurement and tests like protein in the urine, renal function tests and ultrasound were used diabetic nephropathy. Participants were interviewed and their medical chart was reviewed by trained data collectors to determine clinical and related factors. Clients’ weight, height and blood pressure was measured in line with standard protocol. Data quality was assured by giving training prior to data collection and data collectors were supervised and applied measurements at least twice and the average was taken with the nearest value of 0.01. Routinely, diabetes patients who had follow-up in diabetic clinic of each hospital were ordered to come to the next visit with their FBS result and data collectors used the newly FBS result. The data collection tools and instruments used were developed by for this study after reviewing different related literatures.

Reliability and validity

The Cronbach’s alphas for this study was below 0.5 which is due to the questionnaires we used were self-developed and unstandardized. Content validity was ensured by pre-testing the data collection tool on 5% of diabetes. The tool was modified based on the observed findings from the pre-test result. Some questions having ambiguous meaning were rewritten for better understanding of study participants.

Data processing and statistical analysis

Data were cleaned, coded and entered into Epi-Data 3.1 and exported into SPSS version 23 for statistical analysis. Frequency tables with percentage, median, and interquartile range (IQR) was used to describe study findings. Variables with p-value ≤ 0.25 in the binary logistic regression (age, marital status, residence, educational level, occupation, duration of diabetes, medication regimen, physical activity, hypertension and adherence to diet) were entered into multivariable logistic regression analysis. We used crude odds ratio (COR) and adjusted odds ratio (AOR) at 95% to determine the strength of association. Model fitness was verified by Hosmer and Lemeshow model fit and variance inflation factor tested variables multicollinearity. Lastly, variables with a p-value ≤ 0.05 were declared as statistically significant.

Results

Socio-demographic characteristics of participants

A total of 335 type 2 diabetes mellitus were took part in the study. The median age of participants was 53 years (IQR: 45–60 years). More than half of the clients [183 (54.6%)] were males. Majority of individuals [302 (90.1%)] were married. Quarter of [78 (23.3%)] them did not attend formal education and three-forth [259 (77.3%)] individuals were urban dwellers (Table 1).
Table 1
Socio-demographic characteristics of type-2 diabetes mellitus at Dessie town hospitals, Ethiopia 2020 (n = 335)
Variable
Categories
Frequency (%)
Microvascular complications
No
Yes
Age
20–39 years
37 (11.0)
30
7
40–59 years
195 (58.2)
139
56
60–87 years
103 (30.8)
39
64
Sex
Male
183 (54.6)
118
65
Female
152 (45.4)
90
62
Marital status
Never married
33 (9.9)
24
9
Married
302 (90.1)
184
118
Residence
Urban
259 (77.3)
174
85
Rural
76 (22.7)
34
42
Education
No read and write
78 (23.3)
31
47
Grade 1–8
84 (25.1)
53
31
Grade 9–10
82 (24.5)
59
23
Certificate and above
91 (27.2)
65
26
Occupation
Employed
73 (21.8)
49
24
Private workers*
117 (34.9)
83
34
Peasants
37 (11.0)
18
19
House wife
65 (19.4)
34
31
Others**
43 (12.9)
24
19
Private worker*: manufacturer, daily laborer, vehicle driver, mechanic, and wholesalers
Others**: unemployed and retiree

Prevalence of microvascular diabetic complications

In this study, the prevalence of at least one microvascular diabetic complications was 37.9% (95% CI 32.5%-43.3%). Specifically, the prevalence of retinopathy, 24.8% (95% CI 20.3–29.6%), nephropathy, 16.1% (95% CI 12.2–20.3%), and neuropathy, 8.1% (95% CI 5.1–11%) among type 2 diabetes mellitus (Fig. 1).

Behavioral and clinical characteristics of type 2 diabetes mellitus patients

In this study, majority of individuals [269 (80.3%)] and [205 (61.2%)] had no family history of diabetes and diabetic education of ≤ 5 years respectively. The drugs of choice for 223 (66.6%) type 2 DM patients were oral drugs. Two hundred and eight (62.1%) diabetes had inadequate physical activity. Majority of them, [297 (88.7%)] and [287 (85.7%)] were non-obese and had poor glycemic control respectively. Only quarter [66 (19.7%)] of individuals has adherence to diet and 231 (69.0%) diabetes had co-morbid hypertension (Table 2).
Table 2
Behavioral and clinical characteristics of type-2 diabetes mellitus patients at Dessie town hospitals, Ethiopia 2020 (n = 335)
Parameters
Categories
Number
Percentage
Family history of diabetes
Yes
66
19.7
No
269
80.3
Duration of diabetes
≤ 5 years
205
61.2
> 5 years
130
26.4
Medication regimen
Drugs (OHA)
223
66.6
Both oral & insulin
84
25.1
Insulin only
28
8.3
Physical activity
Good*
127
37.9
Poor**
208
62.1
Obesity
Yes
38
11.3
No
297
88.7
Hypertension
Yes
104
31.0
No
231
69.0
Adherence to diet
Yes
66
19.7
No
109
84.5
Glycemic control
Good
48
14.3
Poor
287
85.7
OHA oral hypoglycemic agent, Good* perform at least 150 min/week (3 days) of moderate intensity exercise, Poor** had not exercised at all or perform less than 150 min/week

Predictors of microvascular complications among type 2 diabetes mellitus patients

In bi-variable logistic analysis, age, marital status, residence, educational level, occupation, duration of diabetes, medication regimen, physical activity, co-morbid hypertension and adherence to diet had p-value ≤ 0.2 and hence were entered in to multivariable binary logistic analysis. In the final model, age of participants, duration of diabetes and co-morbid hypertension were statistically significant with the occurrence of microvascular complications.
The odds of developing at least one diabetes microvascular complications for age groups 60–87 yeas was 2.76 times (AOR = 2.76; 95% CI 1.02–7.46) higher as compared to younger diabetes aged 20–39 years. Participants who had a duration of diabetes more than 5 years was 4 times (AOR = 4.09; 95% CI 2.40–6.96) more likely to have microvascular complications in contrary to duration of diabetes 5 years or less. Moreover, diabetic clients with co-morbid hypertension were 3.52 times (AOR = 3.52; 95% CI 2.09–5.95) more likely to acquire microvascular complications than non-hypertensive diabetes (Table 3).
Table 3
Multivariable binary logistic analysis for factors associated to microvascular complications among type-2 diabetes mellitus at Dessie town hospitals, Ethiopia 2020 (n = 335)
Parameters
Categories
Microvascular complications
OR
No
Yes
COR (99% CI)
AOR (95%CI)
Age
20–39 years
30
7
1
1
40–59 years
139
56
1.72 (0.71–4.16)
1.18 (0.46–3.01)
60–87 years
39
64
7.03 (2.82–17.54)
2.76 (1.02–7.46)*
Marital status
Never married
24
9
1
1
Married
184
118
1.71 (0.76–3.80)
0.72 (0.24–2.11)
Residence
Urban
174
85
1
1
Rural
34
42
2.52 (1.50–4.25)
1.68 (0.68–4.11)
Education
No read and write
31
47
1
1
Grade 1–8
53
31
0.38 (0.20–0.72)
0.63 (0.27–1.46)
Grade 9–10
59
23
0.25 (0.133–0.45)
0.46 (0.17–1.20)
Certificate and above
65
26
0.26 (0.14–0.50)
0.54 (0.20–1.46)
Occupation
Employed
49
24
1
1
Private worker
83
34
0.83 (0.44–1.57)
0.53 (0.23–1.24)
Peasants
18
19
2.15 (0.96–4.83)
0.28 (0.07–1.09)
House wife
34
31
1.86 (0.93–3.70)
1.15 (0.44–2.99)
Other
24
19
1.61 (0.74–3.50)
0.37 (0.12–1.101)
Duration of T2DM
 ≤ 5 years
160
45
1
1
 > 5 years
48
82
6.07 (3.73–9.87)
4.09 (2.40–6.96)**
Medication
Drugs (OHA)
158
65
1
1
Regimen
Mixed(oral & insulin)
40
44
2.67 (1.59–4.48)
1.24 (0.56–2.390
Insulin only
10
18
4.37 (1.91–9.98)
2.35 (0.82–6.66)
Hypertension
No
150
81
1
1
Yes
58
46
4.93 (3.06–7.95)
3.52 (2.09–5.95)**
Physical activity
Good
87
40
1
1
Poor
121
87
1.56 (0.98–2.48)
0.93 (0.50–1.72)
Adherence
No
46
20
1
1
Yes
162
107
1.51 (0.85–2.71)
1.17 (0.55–2.47)
OHA oral hypoglycemic agent, T2DM type 2 diabetes mellitus, OR odds ratio, COR crude odds ratios, AOR adjusted odds ratios
Level of significance for factors * p-value < 0.05 and ** p-value < 0.001, Hosmer–Lemeshow goodness-of-fit (p = 0.424), (Variance inflation factor or VIF < 5). Variables such as marital status, residence, educational level, occupation, medication regimen, physical activity and adherence to diet had not significant association (p > 0.05)

Discussion

Nowadays, diabetes mellitus is alarmingly increasing chronic disease that has short and long term sequels if early medication and life-time modification is not sought. Likewise, the disorder is growing faster and becoming serious medical problem in Ethiopia. Microvascular complications could lead to visual, renal and neurological malfunction that all together results in sever morbidity, mortality and negative socio-economic consequences. Hence, identifying associated factors of microvascular complications is very crucial to halt its irreversible consequences.
In the current study, the overall prevalence of microvascular diabetic complications was 37.9%. This proportion is in line with studies in Jimma, Ethiopia 41.5% [28], Metu, Ethiopia 38.5% [29], Ghana 35.3% [24], Saudi Arabia 35.4% [23], Brazil 41.6% [18]. However, this finding is higher than studies in Gondar Ethiopia 20.4% [25], Wollega, Ethiopia 31.2% [26] and Spain 25.2% [20]. On the other hand, this result is lower than studies in Debre Tabor, Ethiopia 43.9% [30], Gurage, Ethiopia 61% [27], Kuwait 61.6% [22], Middle east 45% [15], India 69% [31], China 57.5% [19], Bangladesh 50.4% [21], Greenland, 68% [12] and USA 77% [17]. The difference might be related to sample size, accessibility and advancement of health institutions, patient’s adherence to medication and practice to life style recommendations.
The current study concludes retinopathy (24.8%) is the commonest microvascular complication, and on the other hand, neuropathy (8.1%) is the least microvascular complication which is similar with findings from Debre Tabor, Ethiopia (26.4%, 8.3%) [30], Wollega, Ethiopia (20.7%, 9.8%) [26], Saudi Arabia (14.8%, 5.6%) [23], and Brazil (22.5%, 15.5%) [18] of retinopathy and neuropathy respectively.
In this study factors like increasing age of participants, duration of diabetes and co-morbid hypertension were significantly associated with the presence of microvascular complications.
The odds of developing at least one diabetes microvascular complications for age groups 60–87 yeas was 2.76 times higher as compared to younger diabetes aged 20–39 years. This result is supported by findings from Debre Tabor [30], Wollega [26], Gondar [25], Saudi Arabia [23], Kuwait [22], Bangladesh [21], and China [19]. This is probably due to with advanced age, there combined effect of insulin resistance and loss of beta cells that brings hyperglycemia which in turn causes microvascular damage. Individuals diagnosed with diabetes at advanced age, may not survive long enough for microvascular complications to develop and/or to become clinically noticeable [40]. Moreover, being older is a powerful predictor of vascular damages. They also develop premature complications and death as compared to younger age [41].
Participants who had a duration of diabetes more than 5 years was 4 times more likely to have microvascular complications in contrary to duration of diabetes 5 years or less. This result agreed with studies in Ethiopia (Wollega [26], Gurage [27], Mettu [29]), Ghana [24], Saudi Arabia [23], Kuwait [22], Greenland [12], Greece [9], Brazil [18], and USA [17]. Longer diabetic duration was a potential risk factor for both microvascular diseases and macro-vascular disease independently [16, 18, 42]. In parallel to diabetes longer duration, there is chronic asymptomatic hyperglycemia that ends up with susceptible organ damage at diagnosis [36].
Diabetes clients with co-morbid hypertension were 3.52 times more likely to acquire microvascular complications than non-hypertensive diabetes. This is similar with findings of Mettu, Ethiopia [29], Kuwait [22], Greece [9], China [19], Spain [18], Bangladesh [21], and USA [17]. The possible justification is that high blood pressure accelerates the progress and development of microvascular complications due to increased intracellular hyperglycemia through up regulation of the glucose transporter 1 [43] so that increased plasma glucose level leads to damage of retinal blood vessels and glomeruli, also impair regulation of retinal perfusion [17]. Indeed, hypertension had direct effect on retinal endothelial cell and function that causes cell growth and vasoconstriction which eventually predisposes patients to vascular complications [21, 44].
Unlike to this study, factors such as treatment regimen, poor physical activity and adherence to diet are significant for microvascular complication at Debre Tabor [30], Kuwait [22], Greenland [12], Bangladesh [21], and China [19].
As a limitation, the nature of cross-sectional study doesn’t show case-effect relationship. Moreover, we used document review that lacks completeness for patients’ profile. Also this study was an institution-based so that it is unable to generalize the findings to the entire populations. Recall bias is an expected additional limitation.

Conclusions

The current study findings revealed that microvascular complications of diabetes were widespread particularly diabetic retinopathy that needs immediate intervention to halt its undesirable outcome of vision loss. Increasing age of participants, longer duration of diabetes and co-morbid hypertension were independent predictors of microvascular complications among type 2 diabetes mellitus. The study highlights the urgent need for strengthening and implementing of better diabetic management services at the area. Health professionals also should give more emphasis for diabetes mellitus through early screening and health education (primary prevention). Those aged diabetes patients with long duration of diabetes mellitus, and co-morbidities like hypertension should seek medication abruptly (secondary prevention). There is also a need to early detection and management of microvascular complication (tertiary prevention). Further better and high scale studies like prospective and clinical studies are highly recommended.

Acknowledgements

The authors are very thankful to forward their gratitude to the data collectors, supervisor, study subjects, Dessie town hospitals for their cooperation, and University of Gondar for approval.

Declarations

The study protocol has been examined and approved by the ethical review committee of the School of Medicine, University of Gondar, Ethiopia. This study was done in line with the Helsinki’s declaration. Prior to data collection, the aim and objectives of the study were explained to the study participants and written informed consent was received from each study individuals. Confidentiality is maintained throughout the study.
Not applicable.

Competing interests

No competing of interests to declare.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
2.
Zurück zum Zitat Vithian K. Microvascular complications: pathophysiology and management. Clin med. 2010;10(5):505–9.CrossRef Vithian K. Microvascular complications: pathophysiology and management. Clin med. 2010;10(5):505–9.CrossRef
4.
Zurück zum Zitat A. S. Fauci, D. L. Kasper DLL et al. Harrison’s: principles of internal medicine, 20th edn, vol. 112, The British Journal of Psychiatry. New York: McGraw-Hill; 2018. p. 2851–80. www.accessmedicine.com/harrisons. A. S. Fauci, D. L. Kasper DLL et al. Harrison’s: principles of internal medicine, 20th edn, vol. 112, The British Journal of Psychiatry. New York: McGraw-Hill; 2018. p. 2851–80. www.​accessmedicine.​com/​harrisons.
6.
Zurück zum Zitat Van Dieren S, Beulens JWJ, Van Der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17(SUPPL. 1):3–8. Van Dieren S, Beulens JWJ, Van Der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17(SUPPL. 1):3–8.
8.
Zurück zum Zitat Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62:3–16.CrossRef Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62:3–16.CrossRef
9.
Zurück zum Zitat Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2019;18(2):117–24.CrossRef Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2019;18(2):117–24.CrossRef
12.
Zurück zum Zitat Pedersen ML, Jacobsen JL, Lynge AR. Micro-and macrovascular complications among Greenlanders and Danes with type 2 diabetes mellitus in Nuuk, Greenland Micro- and macrovascular complications among Greenlanders and Danes with type 2 diabetes mellitus in Nuuk. Greenland Int J Circumpolar Health. 2010;69:195–207.CrossRef Pedersen ML, Jacobsen JL, Lynge AR. Micro-and macrovascular complications among Greenlanders and Danes with type 2 diabetes mellitus in Nuuk, Greenland Micro- and macrovascular complications among Greenlanders and Danes with type 2 diabetes mellitus in Nuuk. Greenland Int J Circumpolar Health. 2010;69:195–207.CrossRef
13.
Zurück zum Zitat Girach A, Vignati L. Diabetic microvascular complications—can the presence of one predict the development of another? J Diabetes Complicat. 2006;20:228–37.CrossRef Girach A, Vignati L. Diabetic microvascular complications—can the presence of one predict the development of another? J Diabetes Complicat. 2006;20:228–37.CrossRef
15.
Zurück zum Zitat Cheema S, Maisonneuve P, Zirie M, Jayyousi A, Alrouh H, Abraham A, et al. Risk factors for microvascular complications of diabetes in a high-risk middle east population. J Diabetes Res. 2018;2018:1–8.CrossRef Cheema S, Maisonneuve P, Zirie M, Jayyousi A, Alrouh H, Abraham A, et al. Risk factors for microvascular complications of diabetes in a high-risk middle east population. J Diabetes Res. 2018;2018:1–8.CrossRef
16.
Zurück zum Zitat U. S. Jasper MCO and EBP. Prevalence and clinical pattern of acute and chronic complications in African diabetic patients. Br J Med Med Res. 2014;4(30):4908–17.CrossRef U. S. Jasper MCO and EBP. Prevalence and clinical pattern of acute and chronic complications in African diabetic patients. Br J Med Med Res. 2014;4(30):4908–17.CrossRef
17.
Zurück zum Zitat Ramanathan RS. Correlation of duration, hypertension and glycemic control with microvascular complications of diabetes mellitus at a tertiary care hospital. Integr Mol Med. 2017;4(1):1–4.CrossRef Ramanathan RS. Correlation of duration, hypertension and glycemic control with microvascular complications of diabetes mellitus at a tertiary care hospital. Integr Mol Med. 2017;4(1):1–4.CrossRef
18.
Zurück zum Zitat Cardoso CRL, Salles GF. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients B. J Diabetes Complicat. 2008;22:164–70.CrossRef Cardoso CRL, Salles GF. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients B. J Diabetes Complicat. 2008;22:164–70.CrossRef
20.
Zurück zum Zitat Javier F, Fernández C, Moreno I, Pérez-jáuregui CDG, Silveira B, González T, et al. Microvascular complications and Microvascular complication and risk factors in patients with type 2 diabetes. Elsevier Espania. 2011;58(4):1–6. Javier F, Fernández C, Moreno I, Pérez-jáuregui CDG, Silveira B, González T, et al. Microvascular complications and Microvascular complication and risk factors in patients with type 2 diabetes. Elsevier Espania. 2011;58(4):1–6.
22.
Zurück zum Zitat El-shazly MK, Al-shammeri RM, Moula AMA, Ismail AE, Ismail WA. Prevalence and factors associated with chronic diabetic complications among patients attending primary health care, a multi-centric study in Kuwait. Chronic Diabet Complicat. 2010;46(2):1–12. El-shazly MK, Al-shammeri RM, Moula AMA, Ismail AE, Ismail WA. Prevalence and factors associated with chronic diabetic complications among patients attending primary health care, a multi-centric study in Kuwait. Chronic Diabet Complicat. 2010;46(2):1–12.
23.
Zurück zum Zitat Alaboud AF, Tourkmani AM, Alharbi TJ, Alobikan AH, Abdelhay O, Al Batal SM, et al. Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia. Saudi Med J. 2016;37(12):1408–11.CrossRef Alaboud AF, Tourkmani AM, Alharbi TJ, Alobikan AH, Abdelhay O, Al Batal SM, et al. Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia. Saudi Med J. 2016;37(12):1408–11.CrossRef
24.
Zurück zum Zitat Annani-akollor ME, Addai-mensah O, Fondjo LA, Sallah L, Owiredu E, Acheampong E, et al. Predominant complications of type 2 diabetes in Kumasi : A 4-year retrospective cross-sectional study at a teaching hospital in Ghana. Medicina (B Aires). 2019;55(125):1–11. Annani-akollor ME, Addai-mensah O, Fondjo LA, Sallah L, Owiredu E, Acheampong E, et al. Predominant complications of type 2 diabetes in Kumasi : A 4-year retrospective cross-sectional study at a teaching hospital in Ghana. Medicina (B Aires). 2019;55(125):1–11.
25.
Zurück zum Zitat Fasil AB, Belete AM. Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia. Diabetes Metab Syndr Obes Targets Ther. 2019;12:75–83.CrossRef Fasil AB, Belete AM. Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia. Diabetes Metab Syndr Obes Targets Ther. 2019;12:75–83.CrossRef
26.
Zurück zum Zitat Korsa AT, Genemo ES, Bayisa HG, Dedefo MG. Diabetes mellitus complications and associated factors among adult diabetic patients in selected hospitals of west ethiopia diabetes mellitus complications and associated factors among adult diabetic patients in selected hospitals of West Ethiopia. Open Cardiovasc Med J. 2019;13:41–8.CrossRef Korsa AT, Genemo ES, Bayisa HG, Dedefo MG. Diabetes mellitus complications and associated factors among adult diabetic patients in selected hospitals of west ethiopia diabetes mellitus complications and associated factors among adult diabetic patients in selected hospitals of West Ethiopia. Open Cardiovasc Med J. 2019;13:41–8.CrossRef
28.
Zurück zum Zitat An T. Major microvascular complications and associated risk factors among endocrinology & metabolic syndrome major microvascular complications and associated risk factors among diabetic outpatients in Southwest Ethiopia. Endocrinol Metab Syndr. 2017;6(4):1–10.CrossRef An T. Major microvascular complications and associated risk factors among endocrinology & metabolic syndrome major microvascular complications and associated risk factors among diabetic outpatients in Southwest Ethiopia. Endocrinol Metab Syndr. 2017;6(4):1–10.CrossRef
29.
Zurück zum Zitat Sheleme T, Mamo G, Melaku T, Sahilu T. Prevalence, patterns and predictors of chronic complications of diabetes mellitus at a large referral hospital in Ethiopia: a prospective observational study. Diabetes Metab Syndr Obes Targets Ther. 2020;13:4909–18.CrossRef Sheleme T, Mamo G, Melaku T, Sahilu T. Prevalence, patterns and predictors of chronic complications of diabetes mellitus at a large referral hospital in Ethiopia: a prospective observational study. Diabetes Metab Syndr Obes Targets Ther. 2020;13:4909–18.CrossRef
30.
Zurück zum Zitat Ayele WM. Chronic diabetic complications and associated factors among people with type-2 diabetes mellitus in Debretabor Hospital. Northwest J Diabetes Metab. 2018;11(5):1–6. Ayele WM. Chronic diabetic complications and associated factors among people with type-2 diabetes mellitus in Debretabor Hospital. Northwest J Diabetes Metab. 2018;11(5):1–6.
31.
Zurück zum Zitat Bruce MSP, Mallika MCV. Prevalence of complications of diabetes among patients with diabetes mellitus attending a tertiary care centre in Tamil Nadu. Semicond Sci Technol. 2019;6(4):1452–6. Bruce MSP, Mallika MCV. Prevalence of complications of diabetes among patients with diabetes mellitus attending a tertiary care centre in Tamil Nadu. Semicond Sci Technol. 2019;6(4):1452–6.
32.
Zurück zum Zitat Arambewela MH, Somasundaram NP, Buddhi H, Ranjan P, Kumbukage MP, Mudiyanselage P, et al. Prevalence of chronic complications, their risk factors, and the cardiovascular risk factors among patients with type 2 diabetes attending the diabetic clinic at a tertiary care hospital in Sri Lanka. J Diabetes Res. 2018;2018:1–11.CrossRef Arambewela MH, Somasundaram NP, Buddhi H, Ranjan P, Kumbukage MP, Mudiyanselage P, et al. Prevalence of chronic complications, their risk factors, and the cardiovascular risk factors among patients with type 2 diabetes attending the diabetic clinic at a tertiary care hospital in Sri Lanka. J Diabetes Res. 2018;2018:1–11.CrossRef
34.
Zurück zum Zitat Fawwad A, Mustafa N, Zafar AB, Khalid M. Incidence of microvascular complications of type 2 diabetes: a 12 year longitudinal study from Karachi-Pakistan. Pak J Med Sci. 2018;34(5):1058–63.CrossRef Fawwad A, Mustafa N, Zafar AB, Khalid M. Incidence of microvascular complications of type 2 diabetes: a 12 year longitudinal study from Karachi-Pakistan. Pak J Med Sci. 2018;34(5):1058–63.CrossRef
35.
Zurück zum Zitat Ahmed MB, Yirdachew E, Tefera G. iMedPub journals diabetic complications among follow-up patients: a cross-sectional study at Jimma university specialized hospital diabetic clinic keywords: background. J Clin Mol Endocrinol. 2018;3(45):1–7. Ahmed MB, Yirdachew E, Tefera G. iMedPub journals diabetic complications among follow-up patients: a cross-sectional study at Jimma university specialized hospital diabetic clinic keywords: background. J Clin Mol Endocrinol. 2018;3(45):1–7.
36.
Zurück zum Zitat Eppens MC, Craig ME, Cusumano J, Hing S, Chan A, et al. Prevalence diabetes complication in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2009;29:1300–6.CrossRef Eppens MC, Craig ME, Cusumano J, Hing S, Chan A, et al. Prevalence diabetes complication in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2009;29:1300–6.CrossRef
37.
Zurück zum Zitat Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: the American college of sports medicine and the American diabetes association: joint position statement. Diabetes Care. 2010;33(12):e150.CrossRef Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: the American college of sports medicine and the American diabetes association: joint position statement. Diabetes Care. 2010;33(12):e150.CrossRef
38.
Zurück zum Zitat Care M. Standards of medical care in diabetes—2020. Clin Appl Res Educ. 2020;43:s66-74. Care M. Standards of medical care in diabetes—2020. Clin Appl Res Educ. 2020;43:s66-74.
39.
Zurück zum Zitat Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007–2008 to 2015–2016. JAMA 2018;319(16):1723–25. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007–2008 to 2015–2016. JAMA 2018;319(16):1723–25.
40.
Zurück zum Zitat Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57:2465–74.CrossRef Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57:2465–74.CrossRef
43.
Zurück zum Zitat Bui HDT, Jing X, Lu R, Chen J, Ngo V, Cui Z, Yuanyuan Liu CL, Ma J. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China. Ann Transl Med [Internet]. 2019;7(14):1–10. Available from: https://doi.org/10.21037/atm.2019.06.08 Bui HDT, Jing X, Lu R, Chen J, Ngo V, Cui Z, Yuanyuan Liu CL, Ma J. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China. Ann Transl Med [Internet]. 2019;7(14):1–10. Available from: https://​doi.​org/​10.​21037/​atm.​2019.​06.​08
Metadaten
Titel
Microvascular complications and its predictors among type 2 diabetes mellitus patients at Dessie town hospitals, Ethiopia
verfasst von
Mohammed Abdu Seid
Yonas Akalu
Yibeltal Yismaw Gela
Yitayeh Belsti
Mengistie Diress
Sofonias Addis Fekadu
Baye Dagnew
Mihret Getnet
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
Diabetology & Metabolic Syndrome / Ausgabe 1/2021
Elektronische ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-021-00704-w

Weitere Artikel der Ausgabe 1/2021

Diabetology & Metabolic Syndrome 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.